Clinical Trial Update: Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing vascular effects of rosiglitazone versus glyburide in adults with type 2 diabetes. The study is completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glyburide (glyburide)
• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: St. Paul Heart Clinic | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2012-08-09